Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| CGM & insulin pump management · Michigan | CGM & insulin pump management · Illinois | |
|---|---|---|
| Surgeons, 2024 | 215 | 293 |
| Medicare fee-for-service cases | 22,586 | 40,924 |
| Growth since 2019 (Medicare FFS) | +13%/yr | +22%/yr |
| Forecast cases (Medicare FFS) | 36,200 in 2030 | 73,100 in 2030 |
| Forecast growth | +8.2%/yr to 2030 | +10%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 26.2 | 29.2 |
| Medicare Advantage share | 66% | 47% |
| Out of hospital | 68% (−8 pts since 2019) | 76% (−10 pts since 2019) |
| Cases per surgeon | 105 | 140 |
| Top 10 surgeons' share | 20% | 13% |
| Surgeons growing | 85 | 134 |
| New since the base year | 79 | 106 |
| Likely to stop billing it | 10 by 2026 | 14 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,990 | $1,502 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.